Macrocyclic lactones

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514450, C07D49322

Patent

active

045607745

ABSTRACT:
New and exceptionally potent antineoplastic agents designated bryostatin 1, bryostatin 2 and bryostatin 3 have been isolated from the marine animal Bugula neritina L. (Bryozoan phylum). An x-ray crystallographic analysis led to the assignment of novel structures shown in Charts I, II and III.

REFERENCES:
G. G. Villela, Proc. Soc. Exptl. Biol. Med., 68, 531-533, (1948).
J. S. Carle, et al., J. Org. Chem., 45, 1586-1589, (1980).
J. S. Carle, et al., J. Org. Chem., 46, 3440-3443, (1981).
Y. Okami, et al., J. Antibiot., 29, 1019-1025, (1976).
H. Nakamura, et al., J. Antibiot., 30, No. 9, 714-719, (1977).
G. R. Pettit, et al., Nature, 227, 962-963, (1970).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Macrocyclic lactones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Macrocyclic lactones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic lactones will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1480094

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.